Host Substrate Profiling of SARS-CoV-2 Virus Protease
Host Substrate Profiling of SARS-CoV-2 Virus Protease
批准号:
10270505
负责人:
Ronak R Tilvawala
金额:
$20.98万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-05-15 至 2026-05-31
关键词:
2019-nCoVA549Active SitesAddressAffinityAminesAntiviral AgentsBiological MarkersBiological SciencesBiologyCOVID-19COVID-19 outbreakCOVID-19 severityCOVID-19 treatmentCell LineCell modelCell physiologyCellsCessation of lifeChemicalsCleaved cellCommunicable DiseasesCoronavirusCysteineDataDetectionDevelopmentDiagnosisDiseaseEnzymesEstersEventFamilyFamily PicornaviridaeGlutamineHumanImmune systemIndividualInfectionInnate Immune ResponseInvadedLGLALinkLungMammalian CellMapsMass Spectrum AnalysisMethodsMiddle East Respiratory Syndrome CoronavirusMolecularMonitorMorbidity - disease rateNonstructural ProteinOutcomes ResearchPathogenicityPathologyPathway interactionsPeptide FragmentsPeptide HydrolasesPeptidesPolyproteinsProcessProtein FragmentProteinsProteolysisProteomeProteomicsRecombinantsRepliconResearchResearch Project GrantsResearch ProposalsSARS coronavirusSensitivity and SpecificitySeverity of illnessSiteSpecialistSubstrate SpecificitySuccinimidesSystemTreatment ProtocolsTriad Acrylic ResinUnited States National Institutes of HealthVaccinesValidationViralViral PhysiologyViral PneumoniaVirusVirus DiseasesVirus ReplicationWorkcellular targetingchymotrypsindesigneffective therapyexperimental studyinhibitor/antagonistmortalitynovelpandemic diseasepathogensuccesstherapy development
中文摘要
项目摘要
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是导致病毒性肺炎爆发的原因
2019冠状病毒病(COVID-19)导致广泛的发病率和死亡率。主要蛋白酶(Mpro)
由SARS-CoV-2编码的蛋白质加工病毒多聚蛋白并促进病毒复制。一旦启动,
酶可以通过切割宿主蛋白质来逃避宿主的先天免疫应答。的宿主蛋白质底物
SARS-CoV-2 Mpro尚未得到很好的表征。直接检测宿主蛋白的主要挑战
目标是其低丰度和技术限制与目前的方法的特异性和灵敏度。
因此,该提议旨在开发一种称为N-末端组学的更特异和敏感的方法,
发现Mpro在SARS CoV-2感染过程中产生的独特蛋白片段。具体目标
1)开发和验证新的探针来鉴定由蛋白酶产生的蛋白酶片段,
细胞裂解液中SARS-CoV-2 Mpro和2)鉴定和定量SARS-CoV-2 Mpro的内源性底物
感染的哺乳动物细胞中。拟议研究的理由是,它的成功将促进更大的
了解SARS-CoV-2改变了哪些宿主途径,从而导致严重疾病。
此外,MPro的宿主靶标可用于开发治疗方案,以治疗COVID-19的严重病例。
这项研究的预期结果是,我们的方法将更敏感,更容易适应
宿主底物分析任何病原性蛋白酶,它将有助于绘制细胞途径,
被病原体劫持以入侵宿主系统。
英文摘要
PROJECT SUMMARY
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the viral pneumonia outbreak
of coronavirus disease 2019 (COVID-19) causing widespread morbidity and mortality. Main protease (Mpro)
encoded by SARS-CoV-2 processes the viral polyproteins and facilitates viral replication. Once activated, this
enzyme can evade the host innate immune responses by cleaving host proteins. The host protein substrates of
SARS-CoV-2 Mpro are not well characterized. The major challenges with the direct detection of host protein
targets is their low abundance and technical limitations with the specificity and sensitivity of the current methods.
Thus, this proposal is designed to develop a more specific and sensitive approach termed N-terminomics to
discover unique protein fragments that are generated by Mpro during SARS CoV-2 infection. The Specific Aims
of this proposal are: 1) Development and validation of novel probes to identify protease fragments generated by
SARS-CoV-2 Mpro in cell lysate and 2) Identify and quantify the endogenous substrates of SARS-CoV-2 Mpro
in infected mammalian cells. The rationale for the proposed research is that its success would facilitate a greater
understanding of which host pathways are altered by this SARS-CoV-2 to cause a severe disease condition.
Moreover, host targets of MPro can be used to develop treatment regimens to treat severe cases if COVID-19.
The expected outcome of this research is that our approach will be more sensitive and readily adaptable for the
host substrate profiling of any pathogenic proteases and it will aid in mapping cellular pathways which are
hijacked by pathogens to invade the host system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host Substrate Profiling of SARS-CoV-2 Virus Protease
-
批准号:10267801
-
项目类别:
-
资助金额:$14.34万
-
财政年份:2020
-
负责人:Ronak R Tilvawala
-
依托单位:
Host Substrate Profiling of SARS-CoV-2 Virus Protease
-
批准号:10460251
-
项目类别:
-
资助金额:$20.95万
-
财政年份:2016
-
负责人:Ronak R Tilvawala
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于多重精准选择性碳氢官能化合成策略的抗A549/HepG2活性先导化合物发现及其作用靶标研究
-
批准号:22007020
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:周志
-
依托单位:
导向抗HepG2/A549先导化合物发现和结构优化的多重精准选择性C-H键官能化反应研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:周志
-
依托单位:
内蒙古白云鄂博稀土矿区大气可吸入颗粒物对A549细胞毒理研究
-
批准号:81473017
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2014
-
负责人:孙涓
-
依托单位:
用于识别癌细胞A549的磁共振和荧光双功能探针的研究
-
批准号:21305156
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2013
-
负责人:陈世桢
-
依托单位:
DNA甲基化参与非小细胞肺癌细胞(A549/DDP)顺铂耐药的研究
-
批准号:81101650
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:张有为
-
依托单位:
白藜芦醇诱导人肺癌A549细胞PML蛋白自噬性降解的机制研究
-
批准号:81172089
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:李冠武
-
依托单位:
hTERT启动子调控下CD137L在肺癌A549细胞中的表达及其抑制肿瘤免疫的实验研究
-
批准号:81172140
-
项目类别:面上项目
-
资助金额:64.0万元
-
批准年份:2011
-
负责人:束永前
-
依托单位:
Id3在肺腺癌中的表达分析及其对A549肺腺癌细胞增殖影响的机制研究
-
批准号:81171652
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:李晓军
-
依托单位:
姜黄素调控肺腺癌A549细胞株SP细胞Wnt信号通路的研究
-
批准号:81001578
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2010
-
负责人:李小江
-
依托单位:
PTEN抑制A549肺癌细胞趋电性及调控直流电场对肺癌转移诱导的研究
-
批准号:81000938
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:闫小龙
-
依托单位: